Similarly, the LEADER trial with liraglutide showed a 13% reduction in MACE in patients with type 2 diabetes and high cardiovascular risk
GLP-1 receptor agonists work by: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps regulate blood sugar levels Slowing gastric emptying , meaning food remains in the stomach longer, promoting feelings of fullness Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger signals and food cravings Decreasing glucagon secretion , which helps prevent excessive glucose production by the liver Most GLP-1 agonists are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation, though oral semaglutide (Rybelsus) is also available
Q5: How do you reconstitute tesamorelin
Cloudiness, particles, or color changes are definitive red flags, but clear, colorless solution is not a guarantee of full potency
Manufacturers market the same molecule under separate brands for different approved uses